INTS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Intensity Therapeutics Inc (INTS) does not present a compelling buy opportunity for a beginner investor with a long-term strategy at this time. The lack of positive financial performance, absence of significant trading trends, and no strong proprietary trading signals suggest holding off on investment until further catalysts or improvements arise.
The MACD is positive and expanding, indicating slight bullish momentum. However, the RSI is neutral at 60.555, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The price is trading near resistance levels (R1: 8.892), which could limit further upside in the short term.
The MACD indicates slight bullish momentum, and the stock closed with a 9.55% gain in regular market hours.
No recent news, no significant hedge fund or insider trading trends, and poor financial performance in the latest quarter. The stock also lacks valuation data and recent congress trading activity.
In Q3 2025, the company reported no revenue growth (0% YoY), a net income drop of -23.97% YoY, and a significant EPS decline of -76.00% YoY. Gross margin remains at 0%. Overall, financial performance is weak.
No data available for analyst ratings or price target changes.
